Certuity LLC purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,400 shares of the company’s stock, valued at approximately $258,000. Several other hedge funds have also added […]